Vaginal Clindamycin in Preventing Preterm Birth and Peripartal Infections in Asymptomatic Women With Bacterial Vaginosis: A Randomized, Controlled Trial

Obstetrics and Gynecology

Volumn 97, Issue 5, 2001, Pages 643-648

  Kekki, M ^a   Kurki, T ^a   Pelkonen, J ^a   Kurkinen Raty M ^a   Cacciatore, B ^b   Paavonen, J ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c Vihti Health Center   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; INTRAVAGINAL DRUG ADMINISTRATION; MASS SCREENING; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT OUTCOME; VAGINA SMEAR; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; CLINDAMYCIN; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVENTION STUDIES; MASS SCREENING; OBSTETRIC LABOR, PREMATURE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VAGINAL SMEARS; VAGINOSIS, BACTERIAL;

EID: 0035350552     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-200105000-00001     Document Type: Article

References (29)

1. Romero R, Mazor M, Munoz H, Gomez R, Galasso M, Sherer DM. The preterm labor syndrome. N Y Acad Sci 1994;734:414-29.
2. Minkoff H. Prematurity: Infection as an etiologic factor. Obstet Gynecol 1983;62:137-44.
3. McGregor J. Prevention of preterm birth: New initiatives based on microbial-host interactions. Obstet Gynecol Surv 1988;43:1-14.
4. Gravett MG, Hummel D, Eschenbach DA, Holmes KK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986;67:229-37.
5. Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent association of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899-903.
6. Kurki T, Sivonen A, Renkonen O-V, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173-7.
7. Minkoff H, Grunebaum AN, Schwartz RH. Risk factors for prematurity and premature rupture of membranes: A prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984;150:965-72.
8. Hay P, Lamont R, Taylor-Robinson D, Morgan J, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308:295-8.
9. Meis PJ, Goldenberg RL, Mercer B, Moawad A, Das A, McNellis D, et al. The preterm prediction study: Significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1995;173:1231-5.
10. Hillier S, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995;333:1737-42.
11. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: A placebo-controlled double-blind study. Am J Obstet Gynecol 1994;171:345-9.
12. McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W, et al. Prevention of premature birth by screening and treatment for common genital tract infections: Results of a prospective controlled evaluation. Am J Obstet Gynecol 1995;173:157-67.
13. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erytromycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-6.
14. McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, Harvey JA, Bof A, et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): A randomized, placebo controlled trial. Br J Obstet Gynaecol 1997; 104:1391-7.
15. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 2000;342:534-40.
16. Charles D, Larsen B. Puerperal sepsis. In: Turnbull A, Chamberlein G, eds. Obstetrics. Edinburgh: Churchill Livingstone, 1989:917-32.
17. Kurkinen-Räty M, Vuopala S, Koskela M, Kekki M, Kurki T, Paavonen J, et al. A randomized controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. Br J Obstet Gynaecol 2000;107:1427-32.
18. Spiegel CA, Amsel R, Eschenbach DA, Schoenknecht F, Holmes KK. Diagnosis of bacterial vaginosis by direct Gram stain of vaginal fluid. J Clin Microbiol 1983;18:170-7.
19. Morris J, Gardner M. Calculating confidence intervals for relative risks, odds ratios, and standardized ratios and rates. In: Gardner M, Altman D, eds. Statistics with confidence. London: British Medical Journal, 1989:50-63.
20. Hollis S, Cambell F. What is meant by intention to treat analysis? Survey of published randomized controlled trials. BMJ 1999;319:670-4.
21. Hillier S, Krohn MA, Watts DM, Wolner-Hanssen P, Eschenbach D. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 1990;76:407-13.
22. Andres FJ, Parker R, Hosein I, Benrubi GI. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: A prospective double-blind clinical trial. South Med J 1992;85:1077-80.
23. Hay PE, Morgan D, Ison C, Bhide SA, Romney M, McKenzie P. A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol 1994;101:1048-53.
24. Hillier SL, Krohn MA, Nugent RP, Gibbs RS. Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women. Vaginal infections and prematurity study group. Am J Obstet Gynecol 1992;166:938-44.
25. McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: Results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170:1048-60.
26. Kekki M, Kurki T, Paavonen J, Rutanen E-M. Insulin-like growth factor binding protein-1 in cervix as a marker of infectious complications in pregnant women with bacterial vaginosis. Lancet 1999;353:1494.
27. Lamont RF. Antibiotics for the prevention of preterm birth. N Engl J Med 2000;342:581-2.
28. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000;342:1500-7.
29. Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: A randomized placebo-controlled double-blind trial. Br J Obstet Gynaecol 1999;106:652-7.